Back to Search Start Over

Tfr2 suppression benefits β-thalassemic erythropoiesis.

Authors :
Ginzburg YZ
Fleming RE
Source :
Blood [Blood] 2018 Nov 22; Vol. 132 (21), pp. 2215-2216.
Publication Year :
2018

Abstract

Competing Interests: Conflict-of-interest disclosure: Y.Z.G. serves as a consultant for La Jolla Pharmaceutical Company and has received funding from ApoPharma; R.E.F. serves on the Medical Advisory Board of Protagonist Therapeutics.

Subjects

Subjects :
Animals
Disease Models, Animal
Mice
Receptors, Transferrin
Erythropoiesis
beta-Thalassemia

Details

Language :
English
ISSN :
1528-0020
Volume :
132
Issue :
21
Database :
MEDLINE
Journal :
Blood
Publication Type :
Academic Journal
Accession number :
30467188
Full Text :
https://doi.org/10.1182/blood-2018-10-876110
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details